Launch in new window

Dry Cleaning - Let Me Grow and You'll See the Fruit

You are here

The Wire with Caeden

Latest bCasts • View all

Dear Science w/ Dr. Cushla McGoverin: 10th December, 2024

Dear Science w/ Dr. Cushla McGoverin: 10th December, 2024 Cushla McGoverin: 10th December, 2024, 15.55 MB
Tue 10 Dec 2024

This week on Dear Science, our expert Doctor Cushla McGoverin chatted with us about what latrines teach us about people, climate variation affecting Chinese dynasties, and invasive species becoming threatened.

Thanks to MOTAT, the museum inspiring the innovators of tomorrow!

New Funding for Respiratory Medications w/ Professor Bob Hancox: 10th December, 2024.

New Funding for Respiratory Medications w/ Professor Bob Hancox: 10th December, 2024. , 20.74 MB
Tue 10 Dec 2024

Pharmac recently announced its decision to bring back funding for the respiratory medicine, palivizumab, beginning on the 1st of January, 2025. Palivizumab is used to prevent respiratory syncytial virus (RSV) in children and babies, but went unfunded for a year after October of 2023. 

Alongside the new palivizumab funding announcement, Pharmac also announced funding for a new triple inhaler for people with chronic obstructive pulmonary disease (COPD).

Producer Athena spoke to University of Otago Professor, and Medical Director at the Asthma and Respiratory Foundation New Zealand, Bob Hancox, about the effectiveness of palivizumab, the benefits of the new triple inhaler, and what these funding announcements mean for Kiwis with respiratory issues.

New Funding for a Breast Cancer Drug, Enhertu w/ Breast Cancer Foundation Chief Executive, Ah-Leen Rayner: 10th December, 2024.

New Funding for a Breast Cancer Drug, Enhertu w/ Breast Cancer Foundation Chief Executive, Ah-Leen Rayner: 10th December, 2024. , 11.79 MB
Tue 10 Dec 2024

Pharmac has announced its decision to fund the drug, Enhertu, used for slowing the advancement of the HER2-positive form of breast cancer, beginning on the 1st of January, 2025. Alongside this funding, two eligibility restrictions will be removed.

HER2-positive breast cancer is an aggressive form of breast cancer, where the human epidermal growth factor receptor 2 protein is present, and encourages the growth of cancer cells.

Producer Athena spoke to Chief Executive at the Breast Cancer Foundation New Zealand, Ah-Leen Rayner, about how Enhertu compares to other breast cancer medicines, the removal of eligibility restrictions, and how the Breast Cancer Foundation pushed for this change.

The geopolitical consequences of the fall of Assad w/ Associate Professor Stephen Hoadley: 10th December, 2024

The geopolitical consequences of the fall of Assad w/ Associate Professor Stephen Hoadley: 10th December, 2024 The geopolitical consequences of the fall of Assad w/ Associate Professor Stephen Hoadley: 10th December, 2024, 10.97 MB
Tue 10 Dec 2024

This past week has seen the reign of Syrian President Bashar Al-Assad collapse, his rule toppled by a group of United States backed rebels. The vacuum left by his absence is expected to be felt by those within and outside of Syria. 

To help explain the geopolitical impacts of the fall of the Assad regime, Wire host Castor spoke to Associate Professor Stephen Hoadley.

The Wire w/ Castor: 10th December 2024

The Wire w/ Castor: 10th December 2024 The Wire w/ Castor: 10th December 2024, 109.01 MB
Tue 10 Dec 2024

For Dear Science this week, our expert Doctor Cushla McGoverin chatted with us about what latrines teach us about people, climate variation affecting Chinese dynasties, and invasive species becoming threatened. 

In our weekly catchup with the National Party, Wire host Castor spoke to MP Tom Rutherford about the government’s police staffing targets and changes to national insulation standards. 

They also spoke to Associate Professor Steve Hoadley about the geopolitical consequences of the fall of the Assad regime in Syria. 

Producer Athena spoke to Medical Director at the Asthma and Respiratory Foundation New Zealand, and Professor at the University of Otago, Bob Hancox, about Pharmac’s decision to fund respiratory medicines: pali-vizu-mab, and a new triple inhaler.

And they spoke to the Breast Cancer Foundation New Zealand's Chief Executive, Ah-Leen Rayner about Pharmac’s decision to fund a new breast cancer drug, Enhertu

Police staffing numbers and new insulation guidelines w/ the National Party’s Tom Rutherford: 10th December, 2024

Police staffing numbers and new insulation guidelines w/ the National Party’s Tom Rutherford: 10th December, 2024 Police staffing numbers and new insulation guidelines w/ the National Party’s Tom Rutherford: 10th December, 2024, 9.62 MB
Tue 10 Dec 2024

Last election, one of the National Party’s main campaign promises was to be ‘tough on crime’, promising to increase police coverage and penalties for crimes. A target was set to increase the number of police officers by 500 by November 2025, however some police leaders today say this goal is unrealistic. 

The government also announced this week some shakeups to insulation standards, which they say should make houses more affordable. 

In our weekly catchup with the National Party’s Tom Rutherford, Wire host Castor spoke to him about police staffing targets and new insulation standards.

Governments Methane Review, the impacts to climate change and the possible prospects coming to the meat and dairy industries w/ Greenpeace’s Agricultural Campaign Spokesperson Amanda Larsson: 9 December, 2024

Governments Methane Review, the impacts to climate change and the possible prospects coming to the meat and dairy industries w/ Greenpeace’s Agricultural Campaign Spokesperson Amanda Larsson: 9 December, 2024 Governments Methane Review, the impacts to climate change and the possible prospects coming to the meat and dairy industries w/ Greenpeace’s Agricultural Campaign Spokesperson Amanda Larsson: 9 December, 2024, 19.34 MB
Mon 9 Dec 2024

As of last week the government's methane review report was slammed by Greenpeace for what they say  is the coalition government manipulating of numbers of shirk responsibility in the fight against climate crisis. 

This comes as a result of livestock being one of the biggest contributors for man-made methane within Aotearoa and especially within the meat & dairy industry. 

Producer Yesenia spoke to Greenpeace’s Agricultural Campaign Spokesperson Amanda Larsson about the impacts the review has on an agricultural scale, possible strategies to reduce methane production from the meat and dairy industry and the prospects of reducing methane for the future. 

 

New Zealand species are among the most vulnerable to extinction w/ The Victoria University of Wellington's Dr Julie Deslippe: 9th December, 2024

New Zealand species are among the most vulnerable to extinction w/ The Victoria University of Wellington's Dr Julie Deslippe: 9th December, 2024 New Zealand species are among the most vulnerable to extinction w/ The Victoria University of Wellington's Dr Julie Deslippe: 9th December, 2024 , 8.24 MB
Mon 9 Dec 2024

New Zealand and Australian species are among the most vulnerable to extinction in a warming world, according to a global analysis of 30 years of research.

The research found that Amphibians; species from mountain, island, and freshwater ecosystems; and species inhabiting South America, Australia, and New Zealand face the greatest threats.

If global warming reaches 1.3°C, 1.6% of species are threatened globally, with risks escalating to nearly 30% of global species at 5.4°C. 

Producer Evie spoke to Senior Lecturer in Science Ecology at the Victoria University of Wellington, Julie Deslippe about the research and what it could mean for Aotearoa’s ecosystem.

Twitter Users Jump Ship to BlueSky Site for better Moderation Policies and Artist Community w/ Associate Professor at the University of Auckland Neal Curtis: 9 December, 2024

Twitter Users Jump Ship to BlueSky Site for better Moderation Policies and Artist Community w/ Associate Professor at the University of Auckland Neal Curtis: 9 December, 2024 Twitter Users Jump Ship to BlueSky Site for better Moderation Policies and Artist Community w/ Associate Professor at the University of Auckland Neal Curtis: 9 December, 2024, 15.69 MB
Mon 9 Dec 2024

As of recently, X formerly known as twitter has seen an exodus of its artistic community ending their time and moving to a new platform called Bluesky. 

The change comes as a result that X would be using visual art to train its AI programs leading many artists to end their time with the Elon Musk hosted app.

Producer Yesenia spoke to Associate Professor in Faculty of Arts at the University of Auckland, Neal Curtis, about artists moving to Bluesky for its moderation policies, How Bluesky is holding space for Artists of any medium to share and how the site is benefitting from this rise of new communities.

The Wire w/ Joel: 9 December, 2024

The Wire w/ Joel: 9 December, 2024 The Wire w/ Joel: 9 December, 2024, 115.1 MB
Mon 9 Dec 2024

This week on the Monday Wire:

For our weekly catch up with the ACT Party's Simon Court, Producer Evie speaks to Simon about government bootcamp participants reoffending, proposed changes to employment law and David Seymour’s incumbent term as Deputy Prime Minister.

News and Editorial Director, and Monday Wire Host, Joel, speaks to Senior Lecturer in the Faculty of Education and Social Work at the University of Auckland, Dr Lisa Darragh, about New Zealand's recent results in the Trends in International Maths and Science Study.

Producer Yesenia speaks to Greenpeace’s Agricultural Campaign Spokesperson, Amanda Larsson, about the government's Methane Review and the impact it has on an agricultural standpoint.

Evie speaks to Senior Lecturer in Science Ecology at Victoria University of Wellington, Julie Deslippe, about 30 years of research revealing that Aotearoa’s species are some of those at the greatest risk of extinction.

And Yesenia speaks to Associate Professor in Faculty of Arts at the University of Auckland, Neal Curtis, about artists ending their time on X, formally Twitter, and shifting to Bluesky for it's moderation policies. 

Whakarongo mai!